Pantoprazol Hikma (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Hikma, is a proton pump inhibitor presented as an intravenous solution for intravenous use. It reduces gastric acid secretion and is employed in the management of acid‑related disorders such as gastro‑esophageal reflux disease, erosive esophagitis, Zollinger‑Ellison syndrome, and to prevent NSAID‑induced gastric ulcers in hospitalized patients.

GNH USA supplies Pantoprazol Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Pantoprazole is used to treat conditions associated with excessive gastric acid production. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by reducing acid exposure. - Erosive esophagitis: promotes healing of inflamed esophageal tissue by maintaining a higher gastric pH. - Zollinger‑Ellison syndrome: controls hyper‑secretion of acid caused by gastrin‑producing tumors. - NSAID‑induced gastric ulcer prevention: protects the gastric mucosa in patients receiving non‑steroidal anti‑inflammatory drugs.

Pantoprazole may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild, transient pain in the head. - Diarrhea: loose stools, often self‑limiting. - Nausea: feeling of sickness or urge to vomit. - Abdominal pain: discomfort in the stomach area.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with breathing difficulty, swelling, and rash. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Hypomagnesemia: low magnesium causing muscle cramps, tremor, or irregular heartbeat.

When using Pantoprazol Hikma, several precautions should be observed to ensure safety and efficacy. - Assess renal function: dosage may need adjustment in severe renal impairment. - Monitor magnesium levels: prolonged therapy can lead to hypomagnesemia. - Evaluate for hepatic disease: use with caution in patients with liver dysfunction. - Review concomitant medications: potential interactions with drugs requiring acidic pH for absorption. - Pregnancy and lactation: use only if benefits outweigh risks, as safety data are limited. - Store at ambient temperature: keep below 25°C, protect from light and moisture in original packaging.

Pantoprazole can affect the pharmacokinetics of several medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Ketoconazole and itraconazole: reduced antifungal absorption due to increased gastric pH. - Atazanavir and nelfinavir: decreased antiviral efficacy. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation parameters. - Digoxin: higher serum levels may occur, monitor cardiac status. - Methotrexate: reduced renal clearance, watch for toxicity.